- Measurement of Serum Ibuprofen and Busulfanum in High Dose Therapy1999 | Second Faculty of Medicine
- Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation2006 | First Faculty of Medicine
- High Dose Therapy with Autologous Stem Cell Transplantation in Patients with Hodgkin's Lymphoma: Long Term Follow-up in Patients Treated in One Center2006 | First Faculty of Medicine
- Intesification of BEAM high dose therapy with autologous stem cell rescue for Non-Hodgkin s lymphomas.1998 | Faculty of Physical Education and Sport
- Comparative Multiplex Polymerase Chain Reaction (PCR) as a Helpful Tool for Monitoring in Patients with LymphomasUndergoing High-dose Therapy (HDT) with Autologous Stem Cell Transplantation (ASCT).2000 | Faculty of Physical Education and Sport
- Comparative Multiplex Polymerase Chain Reaction (PCR) as a Helpful Tool for Monitoring in Patients with LymphomasUndergoing High-dose Therapy (HDT) with Autologous Stem Cell Transplantation (ASCT).2000 | Publication without faculty affiliation
- The impact of CD34+ selection on the outcome high dose therapy with autologous stem cell transplantation in lymphoma patients2001 | First Faculty of Medicine
- The impact of CD34+ selection on the outcome high dose therapy with autologous stem cell transplantation in lymphoma patients2001 | Faculty of Physical Education and Sport
- The Clinical Outcome of Patients with B-cell Lymphoproliferative Disease (B-LPD) Seems to Be Improved by the Success in Induction of Polymerase Chain Reaction (PCR) Negativity Achieved by High Dose Therapy with Autologous Stem Cell TransplantationPublication without faculty affiliation
- Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed multiple myeloma patients: subanalysis of the phase 3 VISTA study2011 | First Faculty of Medicine
- The patients who achieved PCR negativity after high dose therapy with autologous stem cell transplantation for B-cell lymphoproliferative disorder (B-LPD) seem to have better prognosisPublication without faculty affiliation
- Autologous stem cell transplantation for AL amyloidosis –single-center results of a strict risk-adapted approach.2010 | First Faculty of Medicine
- Retrospective Analysis of the Results of High-dose Chemotherapy with the Support of Autologous Blood Stem Cells in Patients with Multiple Myeloma. The Experience of a Single Centre2010 | First Faculty of Medicine
- The impact of addition of rituximab and high dose therapy with autologous stem cell transplantation in patients with diffuse large B-cell lymphoma single centre expirience +1Publication without faculty affiliation
- High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO2018 | Publication without faculty affiliation
- The Outcome of Patients with B-cell Lymphoproliferative Disease (B-LPD) Seems to Be Improved in PCR Negative Patients after High Dose Therapy with Autologous Stem Cell Transplantation or Monoclonal Antibody TherapyPublication without faculty affiliation
- The Clinical Outcome of Patients with B-cell Lymphoproliferative Disease (B-LPD) Seems to Be Improved by the Success in Induction of Polymerase Chain Reaction (PCR) Negativity Achieved by High Dose Therapy with Autologous Stem Cell TransplantPublication without faculty affiliation
- Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial2019 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Combined Therapeutic Modality with Rituximab, Fludarabin and Cyclophosphamide Followed by High Dose Therapy with Autologous Stem Cell Transplantation (ASCT) Leads to Excellent Response Rate and High Probability of Molecular Remission in Chronic Lymphocytic Leukemia (CLL) PatientsPublication without faculty affiliation
- Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.2010 | First Faculty of Medicine
- Hematopoietic stem cell transplantation.1999 | Faculty of Physical Education and Sport
- Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma +12008 | Faculty of Medicine in Hradec Králové
- Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma2008 | First Faculty of Medicine
- Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20(+) Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma2012 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. 54767414MMY3007Publication without faculty affiliation
- Diagnosis and therapy of mantle cell lymphoma2008 | Publication without faculty affiliation
- Follicular lymphoma - standard treatment options in 2007 +12008 | Publication without faculty affiliation